- Home
- GILD vs HSBC Comparison
GILD vs HSBC Comparison
Compare GILD & HSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GILD | HSBC |
|---|---|---|
| Founded | 1987 | 1865 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.0B | 336.4B |
| IPO Year | 2003 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GILD | HSBC |
|---|---|---|
| Price | $148.71 | $104.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 3 |
| Target Price | ★ $148.39 | N/A |
| AVG Volume (30 Days) | ★ 6.4M | 1.1M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | 2.55% | ★ 4.18% |
| EPS Growth | ★ 1684.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $24,689,000,000.00 | N/A |
| Revenue This Year | $4.68 | $14.95 |
| Revenue Next Year | $6.04 | $3.66 |
| P/E Ratio | ★ N/A | $94.79 |
| Revenue Growth | ★ 9.98 | N/A |
| 52 Week Low | $108.46 | $63.55 |
| 52 Week High | $157.29 | $107.92 |
Technical Indicators
Market Signals| Indicator | GILD | HSBC |
|---|---|---|
| Relative Strength Index (RSI) | 68.47 | 52.91 |
| Support Level | $142.93 | $101.73 |
| Resistance Level | $149.38 | $104.66 |
| Average True Range (ATR) | 3.50 | 1.05 |
| MACD | 1.12 | -0.34 |
| Stochastic Oscillator | 91.85 | 49.51 |
Price Performance
Historical ComparisonAbout GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About HSBC HSBC Holdings plc.
Established in 1865 in Hong Kong, London-based HSBC is one of the largest banks in the world, with assets of USD 3 trillion and over 40 million customers worldwide. It operates in more than 50 countries with over 200,000 full-time staff. Hong Kong and the United Kingdom are its two largest markets. The bank offers retail, commercial and institutional banking, global banking and markets, wealth management, and private banking.